Physiatry Reviews for Evidence in PracticePotential Harms With Long-Term Glucocorticoid UseUpadhye, Suneel MD, MSc, FRCPC; Kumbhare, Dinesh MD, MSc, FRCPC, FAAPMRAuthor Information From the Department of Medicine, Division of Emergency Medicine, McMaster University, Hamilton, Ontario, Canada (SU); and Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada (DK). All correspondence and requests for reprints should be addressed to: Dinesh Kumbhare, MD, MSc, FRCPC, FAAPMR, Department of Medicine, Division of Physical Medicine Rehabilitation, University of Toronto, 550 University Avenue, Toronto, Ontario, Canada M5G2A2. Source Article: Strehl C, Bijlsma JWJ, de Wit M, et al: Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Annals Rheum Dis 2016;75:952–7. Take Home Message: Low-dose glucocorticoid exposure (<5 mg prednisone/day) is associated with a low risk of long-term harm for osteoporosis, hyperglycemia/diabetes mellitus, cardiovascular disease, or infections. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.ajpmr.com). American Journal of Physical Medicine & Rehabilitation: January 2018 - Volume 97 - Issue 1 - p 72–74 doi: 10.1097/PHM.0000000000000811 Buy SDC Metrics Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.